Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-03-14 @ 9:31 PM
Study NCT ID:
NCT01549834
Status:
COMPLETED
Last Update Posted:
2014-10-31
First Post:
2012-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Alzheimer's Disease | View |
Keywords: